Peritransplant streptavidin recipient treatment prolongs rat cardiac allograft survival.

Background: Because streptavidin shows high localization in inflamed tissues, it might also interfere with the proliferation of cells involved in allograft rejection.

Methods And Results: Treatment of naïve ACI recipients with 20 mg/kg streptavidin i.p.